(Recording) Collaborative Efforts in Fellow Education: Fellow Driven Initiatives From a Year in COVID

This course contains the recording from a webinar that took place on May 6, 2021and seeks to showcase some of the ways fellows have adapted to a new learning environment. The COVID19 pandemic continues to effect our clinical practice and learning environments. In the past year, endocrinology fellowship programs have had to adapt their learning sessions to having in person learning, online learning, or both. This has resulted in challenges and opportunities for adapting our teaching models in new and exciting directions. Fellows in training have been in the forefront of making changes that can have lasting effects in our fields at their programs and beyond, and this webinar seeks to highlight the many creative ways fellows have taken the lead with adapting their clinical education to a new environment. Program directors have encouraged creativity, and shared them with wider audiences. Program directors have also collaborated with one another, supporting efforts during this time.

This recording will highlight selected innovations in fellowship teaching developed in the past year.

  1. Adapt an existing conference to a format that benefits virtual and in person learning
  2. Develop, organize, and direct online educational programming for an audience of fellows from multiple programs
  3. Highlight and diiscuss the program director’s view of the educational challenges during the pandemic

Target Audience

This recording will be of interest to fellows, program directors, and other educators interested in adapting clinical curriculums to a new, primarily virtual, environment. 

Learning Objectives

This recording will highlight selected innovations in fellowship teaching developed in the past year.

  1. Adapt an existing conference to a format that benefits virtual and in person learning
  2. Develop, organize, and direct online educational programming for an audience of fellows from multiple programs
  3. Highlight and diiscuss the program director’s view of the educational challenges during the pandemic

Additional Information

Target Audience: 
Physician-in-practice
Fellow
Resident
Clinical researcher
Educator/Teacher
Competency Area: 
Professionalism
Medical Knowledge
Practice-based Learning and Improvement
Interpersonal and Communication Skills
Topic Area: 
Quality Improvement and Healthcare Delivery
Level of Outcomes: 
Level 1 (Participation)
Level 2 (Satisfaction)
Level 3A (Learning: Declarative Knowledge (Knows))
Activity summary
Available credit: 
  • 1.00 AMA PRA Category 1 Credits
  • 1.00 CME Certificate of Participation
Course opens: 
06/01/2021
Course expires: 
12/31/2023
Rating: 
0
PROGRAM FACULTY

Renee Amori, MD
Program Chair and Moderator
St. Luke's University Health System

Paul Guido, MD
University of North Caroline

Maria Vamvini, MD
Joslin Diabetes Center
Harvard University

Danica Vodopivec, MD
Boston Medical Center

Diana Athonvarangkul, MD, PhD
Yale New Haven Hospital

Deepika Reddy, MD
University of Utah

Ricardo Correa, MD
University of Arizona College of Medicine - Phoenix

STATEMENT OF INDEPENDENCE

As a provider of CME accredited by the Accreditation Council for Continuing Medical Education, the Endocrine Society has a policy of ensuring that the content and quality of this educational activity are balanced, independent, objective, and scientifically rigorous. The scientific content of this activity was developed under the supervision of the Endocrine Society’s guideline task force.

DISCLOSURE POLICY

The faculty, committee members, and staff who are in position to control the content of this activity are required to disclose to the Endocrine Society and to learners any relevant financial relationship(s) of the individual or spouse/partner that have occurred within the last 12 months with any commercial interest(s) whose products or services are related to the content. Financial relationships are defined by remuneration in any amount from the commercial interest(s) in the form of grants; research support; consulting fees; salary; ownership interest (e.g., stocks, stock options, or ownership interest excluding diversified mutual funds); honoraria or other payments for participation in speakers' bureaus, advisory boards, or boards of directors; or other financial benefits. The intent of this disclosure is not to prevent planners with relevant financial relationships from planning or delivery of content, but rather to provide learners with information that allows them to make their own judgments of whether these financial relationships may have influenced the educational activity with regard to exposition or conclusion. The Endocrine Society has reviewed all disclosures and resolved or managed all identified conflicts of interest, as applicable.

The following faculty reported no relevant financial relationships: Renee Amori, MD; Paul Guido, MD; Maria Vamvini, MD; Danica Vodopivec, MD; Diana Athonvarangkul, MD, PhD; Deepika Reddy, MD; Ricardo Correa, MD

Endocrine Society staff associated with the development of content for this activity reported no relevant financial relationships.

DISCLAIMERS

USE OF PROFESSIONAL JUDGMENT:

The educational content in this activity relates to basic principles of diagnosis and therapy and does not substitute for individual patient assessment based on the health care provider’s examination of the patient and consideration of laboratory data and other factors unique to the patient. Standards in medicine change as new data become available.

DRUGS AND DOSAGES:

When prescribing medications, the physician is advised to check the product information sheet accompanying each drug to verify conditions of use and to identify any changes in drug dosage schedule or contraindications.

POLICY ON UNLABELED/OFF-LABEL USE

The Endocrine Society has determined that disclosure of unlabeled/off-label or investigational use of commercial product(s) is informative for audiences and therefore requires this information to be disclosed to the learners at the beginning of the presentation. Uses of specific therapeutic agents, devices, and other products discussed in this educational activity may not be the same as those indicated in product labeling approved by the Food and Drug Administration (FDA). The Endocrine Society requires that any discussions of such “off-label” use be based on scientific research that conforms to generally accepted standards of experimental design, data collection, and data analysis. Before recommending or prescribing any therapeutic agent or device, learners should review the complete prescribing information, including indications, contraindications, warnings, precautions, and adverse events.

PRIVACY AND CONFIDENTIALITY STATEMENT

The Endocrine Society will record learner’s personal information as provided on CME evaluations to allow for issuance and tracking of CME certificates. The Endocrine Society may also track aggregate responses to questions in activities and evaluations and use these data to inform the ongoing evaluation and improvement of its CME program. No individual performance data or any other personal information collected from evaluations will be shared with third parties.

ACKNOWLEDGMENT OF COMMERCIAL SUPPORT

This educational activity is supported by an independent medical educational grant from the Centers for Disease Control (CDC).

The Endocrine Society is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians. The Endocrine Society has achieved Accreditation with Commendation.

This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education (ACCME) for 1.00 AMA PRA Category 1 Credit. Credit can be claimed for this live activity from 6/1/2021-12/31/2023

Please note that while other accrediting bodies accept AMA PRA Category 1 credit, we can only award and report this credit for MDs/DOs. For those outside of this accreditation, please complete the participation evaluation and use that certificate as proof of attendance to submit to your accrediting body.

Available Credit

  • 1.00 AMA PRA Category 1 Credits
  • 1.00 CME Certificate of Participation